1:21 PM · 25 June 2024

Novo Nordisk climbs 2.2% to all-time high amid Wegovy green light in China 📈

Novo Nordisk
Stocks
NOVOB.DK, Novo Nordisk A/S
-
-

Shares of famous Danish weight-drug loss producer Novo Nordisk (NOVOB.DK) are reaching now all-time highs above 1000 DKK as Wegovy weight-loss treatment received approval from regulators in China.

  • Novo Nordisk didn't comment when exactly it will be selling its products on Chinese market. Supply nor Wegovy prices on Chinese market are not known. According to a Chinese public health study, number of overweight adults in China can reach 540 million by 2030 rising 280% since 2000 level.
  • Novo Nordisk is currently the highest valued, European company and year-to-date Novo risen almost 45%. Yesterday, on Monday 24 June, the company announced $4.1 facility investment in the North Carolina (US), to boost its manufacturing capabilities.

Novo Nordisk (NOVOB.DK, D1 interval)

During last 12 months the most important support zone for Novo Nordisk was near SMA50 (orange line) and in correction scenario levels near 900-920DKK may be important.Source: xStation5

15 October 2025, 5:10 PM

TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?

15 October 2025, 3:05 PM

US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction

15 October 2025, 2:53 PM

Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview

15 October 2025, 1:24 PM

Abbott reports no surprises in Q3, but tariff risks and lowered forecasts drag the share price down💡

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits